Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis
Crossref DOI link: https://doi.org/10.1007/s12325-018-0690-4
Published Online: 2018-04-03
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Campos, Michael A.
Runken, Michael C.
Davis, Angela M.
Johnson, Michael P.
Stone, Glenda A.
Buikema, Ami R.
Text and Data Mining valid from 2018-04-01
Article History
Received: 11 February 2018
First Online: 3 April 2018